Commentary  by Setacci, C. & Sirignano, P.
Eur J Vasc Endovasc Surg (2011) 42, S16eS18CommentaryC. Setacci*, P. SirignanoDepartment of Vascular and Endovascular Surgery, University of Sienna, Viale Bracci 1, I-53100 Siena, ItalyItwas apleasure to re-read this paperbyLondonetal.,1which
was published almost 20 years ago.1 This was not, however,
the first report on subintimal angioplasty (SIA) by the
Leicester group. The principles of the technique had previ-
ously been published by its pioneer (Amman Bolia) in Clinical
Radiology in 1989.2 The London paper1 was, however, to
become a mile-stone which helped to change attitudes
around the world regarding the role of endovascular tech-
niques inpatientswith lower limbarterial occlusivedisease. It
is interesting to recall that at the beginning of the 1990s,
bypass surgery was viewed as being the undisputed ‘gold
standard’ and inadvertent entry into the subintimal space
during angioplasty was viewed as a potentially dangerous
technical error, usually necessitating the procedure to be
abandoned. By contrast, Bolia’s SIA technique deliberately
created a new subintimal lumen and London’s paper1 was the
first substantial series to offer evidence about what was to
become known as SIAwas a useful and safe technique to treat
long femoro-popliteal artery occlusions.
London1 reported a consecutive series of 200 procedures
with an initial technical success of nearly 80%, in a generally
unselected population of patients with lower limb ischaemia.
No formal subgroups analyses were reported, but the paper
did not observe significant differences in outcome with
respect to diabetes, critical limb ischaemia (CLI), site of
occlusion or the length of the lesions. Upon reviewing the
paper (again), a number of observations come to mind. First;
the incidence of CLI was limited to only 22 cases, representing
only 11% of patients in the successful group. The majority of
successfully treated patients were claudicants, with good
runoff vessels, especiallybelowtheknee.This preponderance
of claudicants could certainly bias interpretation of the
outcome data and lead to an over-estimation of the real
potential SIA in CLI patients. Second; it appears thatDOI of original article: 10.1016/S0950-821X(05)80450-5.
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long. However, not withstanding these limitations, London’s
paper had the undoubted effect of revising attitudes towards
the role of endovascular therapy in patientswith long femoro-
popliteal occlusions. Prior to this time, the broad consensus
would have been that distal reconstruction should be the
preferred treatment option.
It is also interesting to observe that nearly 20 years after
publication of London’s paper, the technique of SIA has not
changed substantially. It largely remains faithful to the
teachings of Amman Bolia and it would probably be fair to
say that it (SIA) has not achieved comparable technical
advances in the manner seen with the corporately spon-
sored EVAR revolution following publication of the seminal
paper by Parodi.3 The only change (in recent years) has
been the introduction of dedicated re-entry devices,4e8
which facilitates the use of SIA in some patients with
TASC type C/D lesions. The ‘re-entry’ devices do, however,
somehow betray the original spirit of the SIA method. Citing
London: “The specific advantage offered by subintimal
angioplasty is that it does not require specialized equip-
ment, it is relatively cheap, thus it is not a relatively
difficult procedure and it is non-traumatic”.1
Since 1994, a number of centres have published
outcomes after SIA,9e17 but we still do not have level-1
evidence supporting the effectiveness of SIA. Two meta-
analyses18,19 have, however, published an overview of the
literature. Bown18 observed that the overall technical
success rate for SIA in the literature was acceptable
(approximately 86%), but primary patency rates at one year
(approximately 56%) did not match the high initial success
rate. However, long-term limb salvage was excellent
(approximately 90%) and limb salvage was not only main-
tained at longer follow-up periods, but was comparable
with different degrees of ischaemia severity and the use of
adjunctive stenting. Bown observed that there did not
appear to have been any real change in technical success,
limb salvage or primary patency rates in the time since
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relatively steep in those centres that choose to pursue this
method of angioplasty and who went on to publish their
results. In the second meta-analysis, Met et al.19 concluded
that the role of SIA was still evolving and that at their
hospital, open surgery for CLI had reduced by more than
50% over the preceding decade, indicating that (in their
mind) that a significant proportion of patients could be
treated by SIA. Met’s meta-analysis showed that for CLI, SIA
had an important role despite moderate long-term patency
rates. In effect, SIA seemed to serve as a ‘‘temporary
bypass” during which time wound healing and limb salvage
was obtained. More importantly, SIA could be repeated
should symptoms recur.
Because SIA has generally been associated with lower
patency rates than surgery,20e23 some authorities believe
that open revascularization should remain ‘the gold stan-
dard’ in patients with critical limb ischaemia,24,25 despite
the fact that no randomised trial has specifically compared
SIA with bypass. In the BASIL trial,21 any type of trans-
luminal or subintimal angioplasty procedure was permitted,
but too few patients were eligible for randomization due to
their local anatomy and many patients probably made
a personal choice to choose a minimally invasive option.
When considering the late results of the BASIL Trial, surgical
bypass has been promoted as being superior to angioplasty;
however, the results for SIA remain encouraging. In other
published series detailing outcomes following lower limb
bypass surgery, primary patency rates are better than those
observed in this meta-analysis of SIA, but it is important to
observe that limb salvage rates are virtually identical to
those observed in this study.26e29
In conclusion; after 20 years of clinical practice, SIA
should not just be assessed by primary and secondary
patency criteria, but also by clinical outcomes. It is this
observer’s opinion that attitudes towards the treatment of
CLI need to incorporate patient-oriented outcomes.30,31
Patency and limb salvage rates are examples of physician-
oriented endpoints and we need to define ‘clinical
success’ by achieving all of the following parameters:
patency to the point of wound healing, limb salvage at one
year, maintenance of ambulatory status at one year and
survival.30 SIA is another tool in the armamentarium of the
vascular surgeon and interventionist that should be used in
synergy with surgery and with those other endovascular
techniques to achieve the best clinical success for our
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